Assetmark Inc. Grows Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Assetmark Inc. raised its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 14.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 437 shares of the medical instruments supplier’s stock after purchasing an additional 54 shares during the quarter. Assetmark Inc.’s holdings in Mettler-Toledo International were worth $655,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Capital International Investors increased its position in shares of Mettler-Toledo International by 15.1% during the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock worth $1,431,696,000 after acquiring an additional 141,431 shares during the last quarter. PineStone Asset Management Inc. increased its position in shares of Mettler-Toledo International by 127.4% during the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock worth $362,855,000 after acquiring an additional 145,453 shares during the last quarter. TD Asset Management Inc increased its position in shares of Mettler-Toledo International by 1.9% during the second quarter. TD Asset Management Inc now owns 157,247 shares of the medical instruments supplier’s stock worth $219,767,000 after acquiring an additional 2,866 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Mettler-Toledo International by 32.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock worth $199,777,000 after acquiring an additional 35,048 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Mettler-Toledo International by 88.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock worth $163,290,000 after acquiring an additional 57,509 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

MTD has been the subject of a number of research reports. Wells Fargo & Company decreased their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Robert W. Baird decreased their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. Stifel Nicolaus decreased their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. JPMorgan Chase & Co. lifted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Finally, Evercore ISI lifted their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $1,338.75.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Trading Down 4.7 %

Shares of NYSE MTD opened at $1,179.58 on Friday. The stock has a 50 day simple moving average of $1,385.96 and a 200-day simple moving average of $1,400.67. The company has a market cap of $24.89 billion, a PE ratio of 31.80, a P/E/G ratio of 4.16 and a beta of 1.16. Mettler-Toledo International Inc. has a 12-month low of $1,041.49 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Sell-side analysts forecast that Mettler-Toledo International Inc. will post 40.37 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.